Drug Type Stem cell therapy |
Synonyms- |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Leukodystrophy, Globoid Cell | Phase 2 | US | 01 Apr 2011 | |
Mucopolysaccharidosis I | Phase 2 | US | 01 Apr 2011 | |
Anemia, Sickle Cell | Phase 2 | US | 01 Jan 2005 | |
Cardiac transplant rejection | Phase 2 | - | - | |
Graft vs Host Disease | Phase 2 | - | - | |
Leukodystrophy, Metachromatic | Phase 2 | - | - | |
Leukodystrophy, Metachromatic | Phase 2 | - | - | |
Multiple Sclerosis | Phase 2 | - | - | |
Renal transplant rejection | Phase 2 | - | - | |
Renal transplant rejection | Phase 2 | - | - |
Not Applicable | 108 | jsbnebmddc(mfvavlaflk) = wggbidmyom zygggoxclv (adxoqaeuow ) View more | - | 11 Dec 2023 | |||
jsbnebmddc(mfvavlaflk) = ftopslfgsd zygggoxclv (adxoqaeuow ) View more |